Zurcher Kantonalbank (Zurich Cantonalbank) - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 122 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 4.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8
-100.0%
6
-100.0%
0.00%
Q2 2023$32,460
+0.3%
18,134
+117.9%
0.00%
Q1 2023$32,369
-20.8%
8,321
-30.8%
0.00%
Q4 2022$40,861
-28.3%
12,018
+15.7%
0.00%
Q3 2022$57,000
+21.3%
10,3900.0%0.00%
Q2 2022$47,000
-39.7%
10,390
-2.4%
0.00%
Q1 2022$78,000
+105.3%
10,641
+78.0%
0.00%
Q4 2021$38,000
+8.6%
5,9770.0%0.00%
Q3 2021$35,000
-43.5%
5,9770.0%0.00%
Q2 2021$62,000
-1.6%
5,9770.0%0.00%
Q1 2021$63,000
-32.3%
5,9770.0%0.00%
-100.0%
Q4 2020$93,000
+6.9%
5,9770.0%0.00%0.0%
Q3 2020$87,000
-23.0%
5,9770.0%0.00%0.0%
Q2 2020$113,000
-1.7%
5,9770.0%0.00%0.0%
Q1 2020$115,000
+53.3%
5,977
+53.7%
0.00%0.0%
Q4 2019$75,000
+102.7%
3,8880.0%0.00%
Q3 2019$37,000
+60.9%
3,8880.0%0.00%
Q2 2019$23,0000.0%3,8880.0%0.00%
Q1 2019$23,000
-36.1%
3,8880.0%0.00%
Q4 2018$36,000
-45.5%
3,8880.0%0.00%
-100.0%
Q3 2018$66,0000.0%3,8880.0%0.00%0.0%
Q2 2018$66,0003,8880.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,200,396$30,084,0001.72%
TFS CAPITAL LLC 105,040$987,0000.26%
Tekla Capital Management LLC 500,324$4,703,0000.20%
Piermont Capital Management Inc. 51,080$480,0000.11%
ESSEX INVESTMENT MANAGEMENT CO LLC 55,793$524,0000.09%
Candriam S.C.A. 390,000$3,666,0000.08%
Virtus ETF Advisers LLC 27,446$258,0000.08%
SECOR Capital Advisors, LP 66,484$625,0000.08%
Trexquant Investment LP 29,007$273,0000.04%
PRELUDE CAPITAL MANAGEMENT, LLC 32,196$303,0000.04%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders